Miguel, a 63-year-old Los Angeles teacher, recently marked the 38th anniversary of his diagnosis with HIV. The doctor had told him he would be dead in a couple of years. He lived fearful that each ...
SEATTLE (Reuters) - Full details from a pivotal trial of Gilead Sciences Inc experimental Quad HIV pill show that it caused fewer adverse side effects than the company's current three-drug pill, ...
Rukobia (fostemsavir) is a prescription drug that’s used to treat HIV in certain situations. Rukobia comes as an extended-release oral tablet. Rukobia is used along with other drugs to treat HIV-1 in ...
New EACS 2025 data show once-weekly islatravir and lenacapavir maintain HIV viral suppression for 96 weeks with no resistance ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. A generation has passed since the world saw ...
This is figure 4 from a paper in ACS Pharmacology & Translational Science that used a novel approach to show changes in lipid metabolism and protein expression as a result of treatment with the HIV ...
HIV remains a major global health issue, affecting nearly 40 million people worldwide. Current treatments, known as ...
Scientists are nearing a breakthrough in using CRISPR gene-editing to eliminate HIV from human DNA. Early trials of EBT-101 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback